Society starts molecularimaging trials network

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 12
Volume 30
Issue 12

The SNM has announcedthe formation of theMolecular Imaging ClinicalTrials Network, a multi-institutionaleffort to establishscientifically sound, efficientways to evaluate proposedclinical applicationsof biomarker imaging.

The SNM has announced the formation of the Molecular Imaging Clinical Trials Network, a multi-institutional effort to establish scientifically sound, efficient ways to evaluate proposed clinical applications of biomarker imaging.

The network will provide investigational new drugs to the pharma industry and to molecular imaging researchers to develop the next generation of diagnostic and therapeutic agents, according to SNM officials. It will also coordinate imaging protocols and equipment calibration for multicenter clinical trials.

Scientific investigation under the program should start in the first quarter of 2009.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.